The Direct Effect of Estrogen on Cell Viability and Apoptosis in Human Gastric Cancer Cells

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2014 Jun 18

PMID 24934239

Citations 22

Authors

Jian Qin

Min Liu

Qianshan Ding

Xiang Ji

Yarong Hao

Xiaomin Wu

Jie Xiong

Affiliations

Soon will be listed here.

Abstract

Epidemiology researches indicated that gastric cancer is a male-predominant disease; both expression level of estrogen and expression pattern of estrogen receptors (ERs) influence its carcinogenesis. But the direct effect of estrogen on gastric cancer cells is still unclear. This study aimed to explore the direct effect of β-estradiol (E2) on gastric cancer cells. SGC7901 and BGC823 were treated with a serial of concentrations of E2. The survival rates of both the cell lines were significantly reduced, and the reduction of viability was due to apoptosis triggered by E2 treatment. Caspase 3 was activated in response to the increasing E2 concentration in both SGC7901 and BGC823. Cleaved Caspase 3 fragments were detected, and the expression levels of Bcl-2 and Bcl-xL were reduced. Apoptosis was further confirmed by flow cytometry. The expression level of PEG10, an androgen receptor target gene, was reduced during E2 treatment. Both ERα and ERβ were expressed in these cell lines, and the result of bioinformatics analysis of gastric cancer from GEO datasets indicated that the expression levels of both ERα and ERβ were significantly higher in noncancerous gastric tissues than in gastric cancer tissues. Our research indicated that estrogen can reduce cell viability and promote apoptosis in gastric cancer cells directly; ERs expression level is associated with gastric cancer. Our research will help to understand the mechanism of gender disparity in gastric cancer.

Citing Articles

Impact of Sex Hormones on Glioblastoma: Sex-Related Differences and Neuroradiological Insights.

Rossi J, Zedde M, Napoli M, Pascarella R, Pisanello A, Biagini G Life (Basel). 2025; 14(12.

PMID: 39768232 PMC: 11677825. DOI: 10.3390/life14121523.

Appraising associations between signature lipidomic biomarkers and digestive system cancer risk: novel evidences from a prospective cohort study of UK Biobank and Mendelian randomization analyses.

Sun Y, Cao D, Zhang Y, Wu Y, Jia Z, Cui Y Lipids Health Dis. 2024; 23(1):61.

PMID: 38419059 PMC: 10900802. DOI: 10.1186/s12944-024-02053-9.

Increased Levels of miR-15b-5p and miR-20b-5p in Pancreatic Ductal Adenocarcinoma with Hepatic Metastases.

Dobre M, Poenaru R, Niculae A, Vladut C, Herlea V, Milanesi E Genes (Basel). 2023; 14(8).

PMID: 37628628 PMC: 10454474. DOI: 10.3390/genes14081577.

Missing link between tissue specific expressing pattern of ERβ and the clinical manifestations in LGBLEL.

Zhang X, Zhao P, Ma M, Wu H, Liu R, Liu Z Front Med (Lausanne). 2023; 10:1168977.

PMID: 37457559 PMC: 10346852. DOI: 10.3389/fmed.2023.1168977.

Circulating hormones and risk of gastric cancer by subsite in three cohort studies.

Sanikini H, Biessy C, Rinaldi S, Navionis A, Gicquiau A, Keski-Rahkonen P Gastric Cancer. 2023; 26(6):969-987.

PMID: 37455285 PMC: 10640529. DOI: 10.1007/s10120-023-01414-0.

References

Catz S, Johnson J . Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene. 2001; 20(50):7342-51. DOI: 10.1038/sj.onc.1204926. View

Elmore S . Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35(4):495-516. PMC: 2117903. DOI: 10.1080/01926230701320337. View

Sipponen P, Correa P . Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer. 2002; 5(4):213-9. DOI: 10.1007/s101200200037. View

Okabe H, Satoh S, Furukawa Y, Kato T, Hasegawa S, Nakajima Y . Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res. 2003; 63(12):3043-8. View

Chandanos E, Lagergren J . Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 2008; 44(16):2397-403. DOI: 10.1016/j.ejca.2008.07.031. View

Roy R, Moses M . ADAM12 induces estrogen-independence in breast cancer cells. Breast Cancer Res Treat. 2011; 131(3):731-41. PMC: 3381741. DOI: 10.1007/s10549-011-1431-4. View

Morgan M, Kniss D, McDonnell S . Expression of metalloproteinases and their inhibitors in human trophoblast continuous cell lines. Exp Cell Res. 1998; 242(1):18-26. DOI: 10.1006/excr.1997.3929. View

Chaudhri R, Olivares-Navarrete R, Cuenca N, Hadadi A, Boyan B, Schwartz Z . Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36). J Biol Chem. 2012; 287(10):7169-81. PMC: 3293594. DOI: 10.1074/jbc.M111.292946. View

Nelson A, Fingleton B, Rothenberg M, Matrisian L . Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000; 18(5):1135-49. DOI: 10.1200/JCO.2000.18.5.1135. View

10.

Ma W, Ma C, Hsu C, Wu M, Wu C, Wu C . Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology. 2008; 135(3):947-55, 955.e1-5. PMC: 2753209. DOI: 10.1053/j.gastro.2008.05.046. View

11.

Brekman A, Singh K, Polotskaia A, Kundu N, Bargonetti J . A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation. Breast Cancer Res. 2011; 13(1):R3. PMC: 3109566. DOI: 10.1186/bcr2804. View

12.

Lindblad M, Ye W, Rubio C, Lagergren J . Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev. 2004; 13(12):2203-7. View

13.

Bosch F, Ribes J, Diaz M, Cleries R . Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004; 127(5 Suppl 1):S5-S16. DOI: 10.1053/j.gastro.2004.09.011. View

14.

Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E . Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009; 125(3):666-73. DOI: 10.1002/ijc.24290. View

15.

Tsou A, Chuang Y, Su J, Yang C, Liao Y, Liu W . Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers. J Biomed Sci. 2003; 10(6 Pt 1):625-35. DOI: 10.1159/000073528. View

16.

Ryu W, Kim J, Jang Y, Park S, Um J, Park S . Expression of estrogen receptors in gastric cancer and their clinical significance. J Surg Oncol. 2012; 106(4):456-61. DOI: 10.1002/jso.23097. View

17.

Dai Y, Chen S, Wang L, Pei X, Funk V, Kramer L . Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitors. J Biol Chem. 2011; 286(39):34036-50. PMC: 3190767. DOI: 10.1074/jbc.M111.284216. View

18.

Ohtani M, Ge Z, Garcia A, Rogers A, Muthupalani S, Taylor N . 17 β-estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS mice. Carcinogenesis. 2011; 32(8):1244-50. PMC: 3149202. DOI: 10.1093/carcin/bgr072. View

19.

Chunsong H, Yuling H, Li W, Jie X, Gang Z, Qiuping Z . CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells. J Immunol. 2006; 177(10):6713-22. DOI: 10.4049/jimmunol.177.10.6713. View

20.

Moore R, Faller D . SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells. J Endocrinol. 2012; 216(3):273-85. PMC: 3852670. DOI: 10.1530/JOE-12-0102. View